Proteolysis in illness-associated skeletal muscle atrophy: from pathways to networks

References

• Trends in aging - United States and worldwide. CDC. MMWR Morb Mortal Wkly Rep 2003;52:101–104, 106.
   Google Scholar
• Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clin Nutr 2008;27:793–799.
   PubMed Web of Science ®Google Scholar
• Marquis K, Debigaré R, Lacasse Y, LeBlanc P, Jobin J, Carrier G, et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Amer J Resp Crit Care 2002;166:809–813.
   PubMed Web of Science ®Google Scholar
• Anker SD, Coats AJ. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. Chest 1999;115:836–847.
   PubMed Web of Science ®Google Scholar
• Giles JT, Bartlett SJ, Andersen RE, Fontaine KR, Bathon JM. Association of body composition with disability in rheumatoid arthritis: impact of appendicular fat and lean tissue mass. Arthritis Rheum 2008;59:1407–1415.
   PubMed Web of Science ®Google Scholar
• Tan B, Birdsell L, Martin L, Baracos V, Fearon K. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 2009;15:6973–6979.
   PubMed Web of Science ®Google Scholar
• Prado CM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M, Tonkin K, et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 2009;15:2920–2926.
   PubMed Web of Science ®Google Scholar
• Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002;50:889–896.
   PubMed Web of Science ®Google Scholar
• Arora NS, Rochester DF. Effect of body weight and muscularity on human diaphragm muscle mass, thickness, and area. J Appl Physiol 1982;52:64–70.
   PubMed Web of Science ®Google Scholar
• Srikuea R, Pholpramool C, Kitiyanant Y, Yimlamai T. Satellite cell activity in muscle regeneration after contusion in rats. Clin Exp Pharmacol Physiol 2010;37:1078–1086.
   Google Scholar
• Prado CM, Birdsell LA, Baracos VE. The emerging role of computerized tomography in assessing cancer cachexia. Curr Opin Supp Palliative Care 2009;3:269–275.
   PubMedGoogle Scholar
• Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 2002;82:373–428.
   PubMed Web of Science ®Google Scholar
• Peng J, Schwartz D, Elias JE, Thoreen CC, Cheng D, Marsischky G, et al. A proteomics approach to understanding protein ubiquitination. Nat Biotechnol 2003;21:921–926.
   PubMed Web of Science ®Google Scholar
• Chau V, Tobias JW, Bachmair A, Marriott D, Ecker DJ, Gonda DK, et al. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science 1989;243:1576–1583.
   PubMed Web of Science ®Google Scholar
• Matsumoto ML, Wickliffe KE, Dong KC, Yu C, Bosanac I, Bustos D, et al. K11-linked polyubiquitination in cell cycle control revealed by a K11 linkage-specific antibody. Mol Cell 2010;39:477–484.
   PubMed Web of Science ®Google Scholar
• Shang F, Deng G, Liu Q, Guo W, Haas AL, Crosas B, et al. Lys6-modified ubiquitin inhibits ubiquitin-dependent protein degradation. J Biol Chem 2005;280:20365–20374.
   PubMed Web of Science ®Google Scholar
• Saeki Y, Kudo T, Sone T, Kikuchi Y, Yokosawa H, Toh-e A, et al. Lysine 63-linked polyubiquitin chain may serve as a targeting signal for the 26S proteasome. EMBO J 2009;28:359–371.
   PubMed Web of Science ®Google Scholar
• Hershko A, Heller H, Elias S, Ciechanover A. Components of ubiquitin-protein ligase system. J Biol Chem 1983;258:8206–8214.
   PubMed Web of Science ®Google Scholar
• Haas AL, Rose IA. The mechanism of ubiquitin activating enzyme. J Biol Chem 1982;257:10329–10337.
   PubMedGoogle Scholar
• Pickart CM. Mechanisms underlying ubiquitination. Annu Rev Biochem 2001;70:503–533.
   PubMed Web of Science ®Google Scholar
• Reiss Y, Heller H, Hershko A. Binding sites of ubiquitin-protein ligase. Binding of ubiquitin- protein conjugates and of ubiquitin-carrier protein. J Biol Chem 1989;264:10378–10383.
   PubMed Web of Science ®Google Scholar
• Koegl M, Hoppe T, Schlenker S, Ulrich HD, Mayer TU, Jentsch S. A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell 1999;96:635–644.
   PubMed Web of Science ®Google Scholar
• Ciechanover A, Finley D, Varshavsky A. Ubiquitin dependence of selective protein degradation demonstrated in the mammalian cell cycle mutant ts85. Cell 1984;37:57–66.
   PubMed Web of Science ®Google Scholar
• Kulka RG, Raboy B, Schuster R, Parag HA, Diamond G, Ciechanover A, et al. A Chinese hamster cell cycle mutant arrested at G2 phase has a temperature-sensitive ubiquitin-activating enzyme, E1. J Biol Chem 1988;263:15726–15731.
   PubMedGoogle Scholar
• Kim HT, Kim KP, Lledias F, Kisselev AF, Scaglione KM, Skowyra D, et al. Certain pairs of ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s) synthesize nondegradable forked ubiquitin chains containing all possible isopeptide linkages. J Biol Chem 2007;282:17375–17386.
   PubMed Web of Science ®Google Scholar
• Huibregtse JM, Scheffner M, Beaudenon S, Howley PM. A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc Natl Acad Sci USA 1995;92:2563–2567.
   PubMed Web of Science ®Google Scholar
• Scheffner M, Nuber U, Huibregtse JM. Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thiolester cascade. Nature 1995;373:81–83.
   PubMed Web of Science ®Google Scholar
• Joazeiro CA, Wing SS, Huang H, Leverson JD, Hunter T, Liu YC. The tyrosine kinase negative regulator c-Cbl as a RING-Type, E2- dependent ubiquitin-protein ligase. Science 1999;286:309–312.
   PubMed Web of Science ®Google Scholar
• Lorick KL, Jensen JP, Fang S, Ong AM, Hatakeyama S, Weissman AM. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc Natl Acad Sci USA 1999;96:11364–11369.
   PubMed Web of Science ®Google Scholar
• Deffenbaugh AE, Scaglione KM, Zhang L, Moore JM, Buranda T, Sklar LA, et al. Release of ubiquitin-charged Cdc34-S - Ub from the RING domain is essential for ubiquitination of the SCF(Cdc4)-bound substrate Sic1. Cell 2003;114:611–622.
   PubMedGoogle Scholar
• Furukawa M, Ohta T, Xiong Y. Activation of UBC5 ubiquitin-conjugating enzyme by the RING finger of ROC1 and assembly of active ubiquitin ligases by all cullins. J Biol Chem 2002;277:15758–15765.
   PubMedGoogle Scholar
• Nijman SM, Luna-Vargas MP, Velds A, Brummelkamp TR, Dirac AM, Sixma TK, et al. A genomic and functional inventory of deubiquitinating enzymes. Cell 2005;123:773–786.
   PubMed Web of Science ®Google Scholar
• Gallastegui N, Groll M. The 26S proteasome: assembly and function of a destructive machine. Trends Biochem Sci 2010;35:634–642.
   PubMed Web of Science ®Google Scholar
• Madura K. Rad23 and Rpn10: perennial wallflowers join the melee. Trends Biochem Sci 2004;29:637–640.
   PubMed Web of Science ®Google Scholar
• Yao T, Cohen RE. A cryptic protease couples deubiquitination and degradation by the proteasome. Nature 2002;419:403–407.
   PubMed Web of Science ®Google Scholar
• Lam YA, Xu W, DeMartino GN, Cohen RE. Editing of ubiquitin conjugates by an isopeptidase in the 26S proteasome. Nature 1997;385:737–740.
   PubMed Web of Science ®Google Scholar
• Hanna J, Hathaway NA, Tone Y, Crosas B, Elsasser S, Kirkpatrick DS, et al. Deubiquitinating enzyme Ubp6 functions noncatalytically to delay proteasomal degradation. Cell 2006;127:99–111.
   PubMed Web of Science ®Google Scholar
• Wing SS, Haas AL, Goldberg AL. Increase in ubiquitin-protein conjugates concomitant with the increase in proteolysis in rat skeletal muscle during starvation and denervation atrophy. Biochem J 1995;307:639–645.
   Google Scholar
• Baracos VE, DeVivo C, Hoyle DH, Goldberg AL. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. Amer J Physiol Endo Metab 1995;268:E996–E1006.
   Google Scholar
• Lorite MJ, Thompson MG, Drake JL, Carling G, Tisdale MJ. Mechanism of muscle protein degradation induced by a cancer cachectic factor. Br J Cancer 1998;78:850–856.
   Google Scholar
• Llovera M, Garcia-Martinez C, Agell N, Lopez-Soriano FJ, Argiles JM. Muscle wasting associated with cancer cachexia is linked to an important activation of the ATP-dependent ubiquitin-mediated proteolysis. Int J Cancer 1995;61:138–141.
   PubMed Web of Science ®Google Scholar
• Tiao G, Fagan J, Roegner V, Lieberman M, Wang JJ, Fischer JE, et al. Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. J Clin Invest 1996;97:339–348.
   Google Scholar
• Wing SS. Control of ubiquitination in skeletal muscle wasting. Int J Biochem Cell Biol 2005;37:2075–2087.
   PubMed Web of Science ®Google Scholar
• Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J, et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 2004;18:39–51.
   PubMed Web of Science ®Google Scholar
• Taillandier D, Aurousseau E, Meynial-Denis D, Bechet D, Ferrara M, Cottin P, et al. Coordinate activation of lysosomal, Ca2+-activated and ATP- ubiquitin-dependent proteinases in the unweighted rat soleus muscle. Biochem J 1996;316:65–72.
   Google Scholar
• Temparis S, Asensi M, Taillandier D, Aurousseau E, Larbaud D, Obled A, et al. Increased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats. Cancer Res 1994;54:5568–5573.
   PubMedGoogle Scholar
• Voisin L, Breuille D, Combaret L, Pouyet C, Taillandier D, Aurousseau E, et al. Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+-activated, and ubiquitin- proteasome proteolytic pathways. J Clin Invest 1996;97:1–8.
   Google Scholar
• Attaix D, Taillandier D, Combaret L, Ralliere C, Larbaud D, Aurousseau E, et al. Expression of subunits of the 19S complex and of the PA28 activator in rat skeletal muscle. Mol Biol Rep 1997;24:95–98.
   Google Scholar
• Combaret L, Tilignac T, Claustre A, Voisin L, Taillandier D, Obled C, et al. Torbafylline (HWA 448) inhibits enhanced skeletal muscle ubiquitin-proteasome-dependent proteolysis in cancer and septic rats. Biochem J 2002;361:185–192.
   PubMedGoogle Scholar
• Heng AE, Ventadour S, Jarzaguet M, Pouch-Pelissier MN, Guezennec CY, Bigard X, et al. Coordinate expression of the 19S regulatory complex and evidence for ubiquitin-dependent telethonin degradation in the unloaded soleus muscle. Int J Biochem Cell Biol 2008;40:2544–2552.
   Google Scholar
• Combaret L, Taillandier D, Dardevet D, Bechet D, Ralliere C, Claustre A, et al. Glucocorticoids regulate mRNA levels for subunits of the 19 S regulatory complex of the 26 S proteasome in fast-twitch skeletal muscles. Biochem J 2004;378:239–246.
   PubMed Web of Science ®Google Scholar
• Bossola M, Muscaritoli M, Costelli P, Grieco G, Bonelli G, Pacelli F, et al. Increased muscle proteasome activity correlates with disease severity in gastric cancer patients. Ann Surg 2003;237:384–389.
   PubMed Web of Science ®Google Scholar
• Minnaard R, Wagenmakers AJ, Combaret L, Attaix D, Drost MR, van Kranenburg GP, et al. Ubiquitin-proteasome-dependent proteolytic activity remains elevated after zymosan-induced sepsis in rats while muscle mass recovers. Int J Biochem Cell Biol 2005;37:2217–2225.
   Google Scholar
• Crosas B, Hanna J, Kirkpatrick DS, Zhang DP, Tone Y, Hathaway NA, et al. Ubiquitin chains are remodeled at the proteasome by opposing ubiquitin ligase and deubiquitinating activities. Cell 2006;127:1401–1413.
   PubMedGoogle Scholar
• Combaret L, Adegoke OA, Bedard N, Baracos V, Attaix D, Wing SS. USP19 is a ubiquitin-specific protease regulated in rat skeletal muscle during catabolic states. Am J Physiol Endocrinol Metab 2005;288:E693–E700.
   Google Scholar
• Sundaram P, Pang Z, Miao M, Lu Y, Wing SS. USP19 deubiquitinating enzyme regulates levels of major myofibrillar proteins in L6 muscle cells. Am J Physiol Endocrinol Metab 2009;297:E1283–E1290.
   Google Scholar
• Sundaram P, Pang Z, Miao M, Bedard N, Moore T, Wing SS. Loss of USP19 increases transcription of myofibrillar proteins in L6 muscle cells and decreases muscle wasting in response to denervation in mice J Cachexia Sarcopenia Musc 2010;1:87.
   Google Scholar
• Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001;294:1704–1708.
   PubMed Web of Science ®Google Scholar
• Bdolah Y, Segal A, Tanksale P, Karumanchi SA, Lecker SH. Atrophy-related ubiquitin ligases atrogin-1 and MuRF-1 are associated with uterine smooth muscle involution in the postpartum period. Am J Physiol Regul Integr Comp Physiol 2007;292:R971–R976.
   Google Scholar
• Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 2001;98:14440–14445.
   PubMed Web of Science ®Google Scholar
• Sacheck JM, Hyatt JP, Raffaello A, Jagoe RT, Roy RR, Edgerton VR, et al. Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. FASEB J 2007;21:140–155.
   PubMed Web of Science ®Google Scholar
• Witt SH, Granzier H, Witt CC, Labeit S. MURF-1 and MURF-2 target a specific subset of myofibrillar proteins redundantly: towards understanding MURF-dependent muscle ubiquitination. J Mol Biol 2005;350:713–722.
   PubMed Web of Science ®Google Scholar
• Cohen S, Brault JJ, Gygi SP, Glass DJ, Valenzuela DM, Gartner C, et al. During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation. J Cell Biol 2009;185:1083–1095.
   PubMed Web of Science ®Google Scholar
• Clarke BA, Drujan D, Willis MS, Murphy LO, Corpina RA, Burova E, et al. The E3 ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab 2007;6:376–385.
   PubMed Web of Science ®Google Scholar
• Kedar V, McDonough H, Arya R, Li HH, Rockman HA, Patterson C. Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I. Proc Natl Acad Sci USA 2004;101:18135–18140.
   PubMed Web of Science ®Google Scholar
• Witt CC, Witt SH, Lerche S, Labeit D, Back W, Labeit S. Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2. EMBO J 2008;27:350–360.
   Google Scholar
• Fielitz J, Kim MS, Shelton JM, Latif S, Spencer JA, Glass DJ, et al. Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3. J Clin Invest 2007;117:2486–2495.
   Google Scholar
• Tintignac LA, Lagirand J, Batonnet S, Sirri V, Leibovitch MP, Leibovitch SA. Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase. J Biol Chem 2005;280:2847–2856.
   PubMedGoogle Scholar
• Jogo M, Shiraishi S, Tamura TA. Identification of MAFbx as a myogenin-engaged F-box protein in SCF ubiquitin ligase. FEBS Lett 2009;583:2715–2719.
   Google Scholar
• Lagirand-Cantaloube J, Offner N, Csibi A, Leibovitch MP, Batonnet-Pichon S, Tintignac LA, et al. The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy. EMBO J 2008;27:1266–1276.
   Google Scholar
• Li HH, Kedar V, Zhang C, McDonough H, Arya R, Wang DZ, et al. Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J Clin Invest 2004;114:1058–1071.
   PubMedGoogle Scholar
• Li HH, Willis MS, Lockyer P, Miller N, McDonough H, Glass DJ, et al. Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins. J Clin Invest 2007;117:3211–3223.
   PubMedGoogle Scholar
• Hanai JI, Cao P, Tanksale P, Imamura S, Koshimizu E, Zhao J, et al. The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity. J Clin Invest 2007;117:3940–3951.
   PubMed Web of Science ®Google Scholar
• Cao P, Hanai J, Tanksale P, Imamura S, Sukhatme VP, Lecker SH. Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect. FASEB J 2009;23:2844–2854.
   PubMed Web of Science ®Google Scholar
• Peschard P, Park M. Escape from Cbl-mediated downregulation: a recurrent theme for oncogenic deregulation of receptor tyrosine kinases. Cancer Cell 2003;3:519–523.
   PubMed Web of Science ®Google Scholar
• Nakao R, Hirasaka K, Goto J, Ishidoh K, Yamada C, Ohno A, et al. Ubiquitin ligase Cbl-b is a negative regulator for insulin-like growth factor 1 signaling during muscle atrophy caused by unloading. Mol Cell Biol 2009;29:4798–4811.
   PubMed Web of Science ®Google Scholar
• Kwak KS, Zhou X, Solomon V, Baracos VE, Davis J, Bannon AW, et al. Regulation of protein catabolism by muscle-specific and cytokine-inducible ubiquitin ligase E3a-II during cancer cachexia. Cancer Res 2004;64:8193–8198.
   PubMed Web of Science ®Google Scholar
• Bartel B, Wunning I, Varshavsky A. The recognition component of the N-end rule pathway. EMBO J 1990;9:3179–3189.
   PubMedGoogle Scholar
• Hishiya A, Iemura S, Natsume T, Takayama S, Ikeda K, Watanabe K. A novel ubiquitin-binding protein ZNF216 functioning in muscle atrophy. EMBO J 2006;25:554–564.
   Google Scholar
• Raiborg C, Stenmark H. The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature 2009;458:445–452.
   PubMed Web of Science ®Google Scholar
• Orenstein SJ, Cuervo AM. Chaperone-mediated autophagy: molecular mechanisms and physiological relevance. Semin Cell Dev Biol 2010;21:719–726.
   PubMed Web of Science ®Google Scholar
• Todde V, Veenhuis M, van der Klei IJ. Autophagy: principles and significance in health and disease. Biochim Biophys Acta 2009;1792:3–13.
   PubMed Web of Science ®Google Scholar
• Mehrpour M, Esclatine A, Beau I, Codogno P. Autophagy in health and disease. 1. Regulation and significance of autophagy: an overview. Am J Physiol Cell Physiol 2010;298:C776–C785.
   PubMed Web of Science ®Google Scholar
• Lardeux BR, Mortimore GE. Amino acid and hormonal control of macromolecular turnover in perfused rat liver. Evidence for selective autophagy. J Biol Chem 1987;262:14514–14519.
   PubMed Web of Science ®Google Scholar
• Schworer CM, Mortimore GE. Glucagon-induced autophagy and proteolysis in rat liver: mediation by selective deprivation of intracellular amino acids. Proc Natl Acad Sci USA 1979;76:3169–3173.
   PubMed Web of Science ®Google Scholar
• Ohsumi Y. Molecular dissection of autophagy: two ubiquitin-like systems. Nat Rev Mol Cell Biol 2001;2:211–216.
   PubMed Web of Science ®Google Scholar
• Tanida I, Komatsu M, Ueno T, Kominami E. GATE-16 and GABARAP are authentic modifiers mediated by Apg7 and Apg3. Biochem Biophys Res Commun 2003;300:637–644.
   Web of Science ®Google Scholar
• Axe EL, Walker SA, Manifava M, Chandra P, Roderick HL, Habermann A, et al. Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum. J Cell Biol 2008;182:685–701.
   PubMed Web of Science ®Google Scholar
• Hailey DW, Rambold AS, Satpute-Krishnan P, Mitra K, Sougrat R, Kim PK, et al. Mitochondria supply membranes for autophagosome biogenesis during starvation. Cell 2010;141:656–667.
   PubMed Web of Science ®Google Scholar
• Nakatogawa H, Ichimura Y, Ohsumi Y. Atg8, a ubiquitin-like protein required for autophagosome formation, mediates membrane tethering and hemifusion. Cell 2007;130:165–178.
   PubMed Web of Science ®Google Scholar
• Razi M, Chan EY, Tooze SA. Early endosomes and endosomal coatomer are required for autophagy. J Cell Biol 2009;185:305–321.
   PubMed Web of Science ®Google Scholar
• Furuno K, Goodman MN, Goldberg AL. Role of different proteolytic systems in the degradation of muscle proteins during denervation atrophy. J Biol Chem 1990;265:8550–8557.
   PubMed Web of Science ®Google Scholar
• Wing SS, Goldberg AL. Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. Am J Physiol Endo Metab 1993;264:E668–E676.
   PubMedGoogle Scholar
• Price SR, Bailey JL, Wang X, Jurkovitz C, England BK, Ding X, et al. Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription. J Clin Invest 1996;98:1703–1708.
   Google Scholar
• Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P, et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 2007;6:458–471.
   PubMed Web of Science ®Google Scholar
• Zhao J, Brault JJ, Schild A, Cao P, Sandri M, Schiaffino S, et al. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 2007;6:472–483.
   PubMed Web of Science ®Google Scholar
• Deval C, Mordier S, Obled C, Bechet D, Combaret L, Attaix D, et al. Identification of cathepsin L as a differentially expressed message associated with skeletal muscle wasting. Biochem J 2001;360:143–150.
   Google Scholar
• Mizushima N, Yamamoto A, Matsui M, Yoshimori T, Ohsumi Y. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell 2004;15:1101–1111.
   PubMed Web of Science ®Google Scholar
• Masiero E, Agatea L, Mammucari C, Blaauw B, Loro E, Komatsu M, et al. Autophagy is required to maintain muscle mass. Cell Metab 2009;10:507–515.
   PubMed Web of Science ®Google Scholar
• Ravikumar B, Sarkar S, Davies JE, Futter M, Garcia-Arencibia M, Green-Thompson ZW, et al. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev 2010;90:1383–1435.
   PubMed Web of Science ®Google Scholar
• Arndt V, Dick N, Tawo R, Dreiseidler M, Wenzel D, Hesse M, et al. Chaperone-assisted selective autophagy is essential for muscle maintenance. Curr Biol 2010;20:143–148.
   PubMed Web of Science ®Google Scholar
• Romanello V, Guadagnin E, Gomes L, Roder I, Sandri C, Petersen Y, et al. Mitochondrial fission and remodelling contributes to muscle atrophy. EMBO J 2010;29:1774–1785.
   PubMed Web of Science ®Google Scholar
• Zatz M, Starling A. Calpains and disease. N Engl J Med 2005;352:2413–2423.
   PubMed Web of Science ®Google Scholar
• duVerle D, Takigawa I, Ono Y, Sorimachi H, Mamitsuka H. CaMPDB: a resource for calpain and modulatory proteolysis. Genome Inform 2010;22:202–213.
   PubMedGoogle Scholar
• Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiol Rev 2003;83:731–801.
   PubMed Web of Science ®Google Scholar
• Hanna RA, Campbell RL, Davies PL. Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin. Nature 2008;456:409–412.
   PubMed Web of Science ®Google Scholar
• Moldoveanu T, Gehring K, Green DR. Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains. Nature 2008;456:404–408.
   PubMed Web of Science ®Google Scholar
• Kemp CM, Sensky PL, Bardsley RG, Buttery PJ, Parr T. Tenderness–an enzymatic view. Meat Sci 2010;84:248–256.
   PubMed Web of Science ®Google Scholar
• Sultan KR, Dittrich BT, Pette D. Calpain activity in fast, slow, transforming, and regenerating skeletal muscles of rat. Am J Physiol Cell Physiol 2000;279:C639–C647.
   Google Scholar
• Jones SW, Hill RJ, Krasney PA, O’Conner B, Peirce N, Greenhaff PL. Disuse atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with the regulation of skeletal muscle mass. FASEB J 2004;18:1025–1027.
   PubMed Web of Science ®Google Scholar
• Raastad T, Owe SG, Paulsen G, Enns D, Overgaard K, Crameri R, et al. Changes in calpain activity, muscle structure, and function after eccentric exercise. Med Sci Sports Exerc 2010;42:86–95.
   PubMed Web of Science ®Google Scholar
• Barnoy S, Glaser T, Kosower NS. The calpain-calpastatin system and protein degradation in fusing myoblasts. Biochim Biophys Acta 1998;1402:52–60.
   Google Scholar
• Tidball JG, Spencer MJ. Expression of a calpastatin transgene slows muscle wasting and obviates changes in myosin isoform expression during murine muscle disuse. J Physiol 2002;545:819–828.
   Google Scholar
• Barnoy S, Kosower NS. Caspase-1-induced calpastatin degradation in myoblast differentiation and fusion: cross-talk between the caspase and calpain systems. FEBS Lett 2003;546:213–217.
   Google Scholar
• Busquets S, Garcia-Martinez C, Alvarez B, Carbo N, Lopez-Soriano FJ, Argiles JM. Calpain-3 gene expression is decreased during experimental cancer cachexia. Biochim Biophys Acta 2000;1475:5–9.
   Google Scholar
• Stockholm D, Herasse M, Marchand S, Praud C, Roudaut C, Richard I, et al. Calpain 3 mRNA expression in mice after denervation and during muscle regeneration. Am J Physiol Cell Physiol 2001;280:C1561–C1569.
   Google Scholar
• Murphy RM, Goodman CA, McKenna MJ, Bennie J, Leikis M, Lamb GD. Calpain-3 is autolyzed and hence activated in human skeletal muscle 24 h following a single bout of eccentric exercise. J Appl Physiol 2007;103:926–931.
   Google Scholar
• Laure L, Danièle N, Suel L, Marchand S, Aubert S, Bourg N, et al. A new pathway encompassing calpain 3 and its newly identified substrate cardiac ankyrin repeat protein is involved in the regulation of the nuclear factor-κB pathway in skeletal muscle. FEBS J 2010;277:4322–4337.
   PubMedGoogle Scholar
• Salvesen G, Duckett C. IAP proteins: blocking the road to death’s door. Nat Rev Mol Cell Biol 2002;3:401–410.
   PubMed Web of Science ®Google Scholar
• Baghdiguian S, Martin MM, Richard I, Pons F, Astier C, Bourg N, et al. Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A. Nat Med 1999;5:503–511.
   PubMed Web of Science ®Google Scholar
• Kettelhut IC, Pepato MT, Migliorini RH, Medina R, Goldberg AL. Regulation of different proteolytic pathways in skeletal muscle in fasting and diabetes mellitus. Braz J Med Biol Res 1994;27:981–993.
   Google Scholar
• Supinski GS, Wang WX, Callahan LA. Caspase and calpain activation both contribute to sepsis-induced diaphragmatic weakness. J Appl Physiol 2009;107:1389–1396.
   PubMedGoogle Scholar
• Li Y, Li Y, Feng Q, Arnold M, Peng T. Calpain activation contributes to hyperglycaemia-induced apoptosis in cardiomyocytes. Cardiovasc Res 2009;84:100–110.
   PubMed Web of Science ®Google Scholar
• Mani SK, Balasubramanian S, Zavadzkas JA, Jeffords LB, Rivers WT, Zile MR, et al. Calpain inhibition preserves myocardial structure and function following myocardial infarction. Am J Physiol Heart Circ Physiol 2009;297:H1744–H1751.
   Web of Science ®Google Scholar
• Salazar JJ, Michele DE, Brooks SV. Inhibition of calpain prevents muscle weakness and disruption of sarcomere structure during hindlimb suspension. J Appl Physiol 2010;108:120–127.
   Google Scholar
• Li X, Li Y, Shan L, Shen E, Chen R, Peng T. Over-expression of calpastatin inhibits calpain activation and attenuates myocardial dysfunction during endotoxaemia. Cardiovasc Res 2009;83:72–79.
   Google Scholar
• Smith IJ, Dodd SL. Calpain activation causes a proteasome-dependent increase in protein degradation and inhibits the Akt signalling pathway in rat diaphragm muscle. Exp Physiol 2007;92:561–573.
   PubMed Web of Science ®Google Scholar
• Kramerova I, Kudryashova E, Venkatraman G, Spencer MJ. Calpain 3 participates in sarcomere remodeling by acting upstream of the ubiquitin-proteasome pathway. Hum Mol Genet 2005;14:2125–2134.
   PubMed Web of Science ®Google Scholar
• Varshavsky A. The N-end rule: functions, mysteries, uses. Proc Natl Acad Sci USA 1996;93:12142–12149.
   PubMed Web of Science ®Google Scholar
• Li L, Halaby MJ, Hakem A, Cardoso R, El Ghamrasni S, Harding S, et al. Rnf8 deficiency impairs class switch recombination, spermatogenesis, and genomic integrity and predisposes for cancer. J Exp Med 2010;207:983–997.
   PubMed Web of Science ®Google Scholar
• Rami A, Agarwal R, Spahn A. Synergetic effects of caspase 3 and mu-calpain in XIAP-breakdown upon focal cerebral ischemia. Neurochem Res 2007;32:2072–2079.
   Google Scholar
• Nakagawa T, Yuan J. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol 2000;150:887–894.
   PubMed Web of Science ®Google Scholar
• Chua BT, Guo K, Li P. Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases. J Biol Chem 2000;275:5131–5135.
   PubMed Web of Science ®Google Scholar
• Shi Y. Caspase activation: revisiting the induced proximity model. Cell 2004;117:855–858.
   PubMed Web of Science ®Google Scholar
• Martinon F, Tschopp J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004;117:561–574.
   PubMed Web of Science ®Google Scholar
• Jagoe RT, Goldberg AL. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? Curr Opin Clin Nutr Metab Care 2001;4:183–190.
   PubMed Web of Science ®Google Scholar
• Ogata T, Machida S, Oishi Y, Higuchi M, Muraoka I. Differential cell death regulation between adult-unloaded and aged rat soleus muscle. Mech Ageing Dev 2009;130:328–336.
   Google Scholar
• Yarbrough WM, Mukherjee R, Stroud RE, Meyer EC, Escobar GP, Sample JA, et al. Caspase inhibition modulates left ventricular remodeling following myocardial infarction through cellular and extracellular mechanisms. J Cardiovasc Pharmacol 2010;55:408–416.
   PubMedGoogle Scholar
• Agusti AG, Sauleda J, Miralles C, Gomez C, Togores B, Sala E, et al. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:485–489.
   PubMed Web of Science ®Google Scholar
• Vescovo G, Volterrani M, Zennaro R, Sandri M, Ceconi C, Lorusso R, et al. Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes. Heart 2000;84:431–437.
   PubMed Web of Science ®Google Scholar
• Du J, Wang X, Miereles C, Bailey JL, Debigare R, Zheng B, Price SR, Mitch WE. Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J Clin Invest 2004;113:115–123.
   PubMed Web of Science ®Google Scholar
• Wang XH, Zhang L, Mitch WE, LeDoux JM, Hu J, Du J. Caspase-3 cleaves specific 19 S proteasome subunits in skeletal muscle stimulating proteasome activity. J Biol Chem 2010;285:21249–21257.
   PubMedGoogle Scholar
• Plant PJ, Bain JR, Correa JE, Woo M, Batt J. Absence of caspase-3 protects against denervation-induced skeletal muscle atrophy. J Appl Physiol 2009;107:224–234.
   Google Scholar
• Chopra M, Das P, Sharma AC. Caspase-3 knock-down reverses contractile dysfunction induced by sepsis in adult rat ventricular myocytes. Br J Pharmacol 2010;160:93–100.
   Google Scholar
• Wirawan E, Vande Walle L, Kersse K, Cornelis S, Claerhout S, Vanoverberghe I, et al. Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria. Cell Death Dis 2010;1:e18.
   PubMed Web of Science ®Google Scholar
• Murgia M, Serrano AL, Calabria E, Pallafacchina G, Lomo T, Schiaffino S. Ras is involved in nerve-activity-dependent regulation of muscle genes. Nat Cell Biol 2000;2:142–147.
   PubMed Web of Science ®Google Scholar
• Aguilar V, Alliouachene S, Sotiropoulos A, Sobering A, Athea Y, Djouadi F, et al. S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase. Cell Metab 2007;5:476–487.
   PubMedGoogle Scholar
• Kim JH, Park KC, Chung SS, Bang O, Chung CH. Deubiquitinating enzymes as cellular regulators. J Biochem (Tokyo) 2003;134:9–18.
   PubMed Web of Science ®Google Scholar
• Ma XM, Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol 2009;10:307–318.
   PubMed Web of Science ®Google Scholar
• Bentzinger CF, Romanino K, Cloetta D, Lin S, Mascarenhas JB, Oliveri F, et al. Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab 2008;8:411–424.
   PubMed Web of Science ®Google Scholar
• Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol 2001;3:1009–1013.
   PubMed Web of Science ®Google Scholar
• Pallafacchina G, Calabria E, Serrano AL, Kalhovde JM, Schiaffino S. A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc Natl Acad Sci USA 2002;99:9213–9218.
   PubMed Web of Science ®Google Scholar
• Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 2001;3:1014–1019.
   PubMed Web of Science ®Google Scholar
• Sacheck JM, Ohtsuka A, McLary SC, Goldberg AL. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. Am J Physiol Endocrinol Metab 2004;287:E591–E601.
   PubMed Web of Science ®Google Scholar
• Tran H, Brunet A, Griffith EC, Greenberg ME. The many forks in FOXO’s road. Sci STKE 2003;172:RE5.
   Google Scholar
• Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999;96:857–868.
   PubMed Web of Science ®Google Scholar
• Ramaswamy S, Nakamura N, Sansal I, Bergeron L, Sellers WR. A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell 2002;2:81–91.
   PubMed Web of Science ®Google Scholar
• Furuyama T, Kitayama K, Yamashita H, Mori N. Forkhead transcription factor FOXO1 (FKHR)-dependent induction of PDK4 gene expression in skeletal muscle during energy deprivation. Biochem J 2003;375:365–371.
   PubMed Web of Science ®Google Scholar
• Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, et al. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 2004;14:395–403.
   PubMed Web of Science ®Google Scholar
• Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004;117:399–412.
   PubMed Web of Science ®Google Scholar
• Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998;92:829–839.
   PubMed Web of Science ®Google Scholar
• Lin J, Handschin C, Spiegelman BM. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 2005;1:361–370.
   PubMed Web of Science ®Google Scholar
• Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, et al. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 2002;418:797–801.
   PubMed Web of Science ®Google Scholar
• Arany Z, Lebrasseur N, Morris C, Smith E, Yang W, Ma Y, et al. The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab 2007;5:35–46.
   PubMed Web of Science ®Google Scholar
• Sandri M, Lin J, Handschin C, Yang W, Arany ZP, Lecker SH, et al. PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc Natl Acad Sci USA 2006;103:16260–16265.
   PubMed Web of Science ®Google Scholar
• Goldberg AL. Role of insulin in work-induced growth of skeletal muscle. Endocrinology 1968;83:1071–1073.
   PubMed Web of Science ®Google Scholar
• Hardie DG, Sakamoto K. AMPK: a key sensor of fuel and energy status in skeletal muscle. Physiol 2006;21:48–60.
   PubMed Web of Science ®Google Scholar
• Krawiec BJ, Nystrom GJ, Frost RA, Jefferson LS, Lang CH. AMP-activated protein kinase agonists increase mRNA content of the muscle-specific ubiquitin ligases MAFbx and MuRF1 in C2C12 cells. Am J Physiol Endocrinol Metab 2007;292:E1555–E1567.
   PubMed Web of Science ®Google Scholar
• Nakashima K, Yakabe Y. AMPK activation stimulates myofibrillar protein degradation and expression of atrophy-related ubiquitin ligases by increasing FOXO transcription factors in C2C12 myotubes. Biosci Biotechnol Biochem 2007;71:1650–1656.
   PubMed Web of Science ®Google Scholar
• Beutler BA, Milsark IW, Cerami A. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. J Immunol 1985;135:3972–3977.
   PubMed Web of Science ®Google Scholar
• Dogra C, Changotra H, Wedhas N, Qin X, Wergedal JE, Kumar A. TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine. FASEB J 2007;21:1857–1869.
   PubMed Web of Science ®Google Scholar
• Argiles JM, Lopez-Soriano FJ. The role of cytokines in cancer cachexia. Med Res Rev 1999;19:223–248.
   PubMed Web of Science ®Google Scholar
• von Haehling S, Genth-Zotz S, Anker SD, Volk HD. Cachexia: a therapeutic approach beyond cytokine antagonism. Int J Cardiol 2002;85:173–183.
   PubMed Web of Science ®Google Scholar
• Ladner KJ, Caligiuri MA, Guttridge DC. Tumor necrosis factor-regulated biphasic activation of NF-kappa B is required for cytokine-induced loss of skeletal muscle gene products. J Biol Chem 2003;278:2294–2303.
   PubMedGoogle Scholar
• Penner CG, Gang G, Wray C, Fischer JE, Hasselgren PO. The transcription factors NF-kappab and AP-1 are differentially regulated in skeletal muscle during sepsis. Biochem Biophys Res Commun 2001;281:1331–1336.
   Google Scholar
• Hunter RB, Stevenson E, Koncarevic A, Mitchell-Felton H, Essig DA, Kandarian SC. Activation of an alternative NF-kappaB pathway in skeletal muscle during disuse atrophy. FASEB J 2002;16:529–538.
   PubMed Web of Science ®Google Scholar
• Li YP, Reid MB. NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes. Am J Physiol Regul Integr Comp Physiol 2000;279:R1165–R1170.
   PubMed Web of Science ®Google Scholar
• Williamson DL, Kimball SR, Jefferson LS. Acute treatment with TNF-alpha attenuates insulin-stimulated protein synthesis in cultures of C2C12 myotubes through a MEK1-sensitive mechanism. Am J Physiol Endocrinol Metab 2005;289:E95–E104.
   PubMed Web of Science ®Google Scholar
• Guttridge DC, Mayo MW, Madrid LV, Wang CY, Baldwin AS Jr. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 2000;289:2363–2366.
   PubMed Web of Science ®Google Scholar
• Langen RC, Schols AM, Kelders MC, Wouters EF, Janssen-Heininger YM. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB. FASEB J 2001;15:1169–1180.
   PubMed Web of Science ®Google Scholar
• Cai D, Frantz JD, Tawa NE Jr, Melendez PA, Oh BC, Lidov HG, et al. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 2004;119:285–298.
   PubMed Web of Science ®Google Scholar
• Hunter RB, Kandarian SC. Disruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy. J Clin Invest 2004;114:1504–1511.
   PubMedGoogle Scholar
• Li YP, Chen Y, John J, Moylan J, Jin B, Mann DL, et al. TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J 2005;19:362–370.
   PubMed Web of Science ®Google Scholar
• Clop A, Marcq F, Takeda H, Pirottin D, Tordoir X, Bibe B, et al. A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet 2006;38:813–818.
   PubMed Web of Science ®Google Scholar
• Lee SJ, McPherron AC. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 2001;98:9306–9311.
   PubMed Web of Science ®Google Scholar
• McPherron AC, Lee SJ. Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci USA 1997;94:12457–12461.
   PubMed Web of Science ®Google Scholar
• Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W, et al. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 2004;350:2682–2688.
   PubMed Web of Science ®Google Scholar
• Zimmers TA, Davies MV, Koniaris LG, Haynes P, Esquela AF, Tomkinson KN, et al. Induction of cachexia in mice by systemically administered myostatin. Science 2002;296:1486–1488.
   PubMed Web of Science ®Google Scholar
• Reisz-Porszasz S, Bhasin S, Artaza JN, Shen R, Sinha-Hikim I, Hogue A, et al. Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin. Am J Physiol Endocrinol Metab 2003;285:E876–E888.
   PubMed Web of Science ®Google Scholar
• Durieux AC, Amirouche A, Banzet S, Koulmann N, Bonnefoy R, Pasdeloup M, et al. Ectopic expression of myostatin induces atrophy of adult skeletal muscle by decreasing muscle gene expression. Endocrinology 2007;148:3140–3147.
   Google Scholar
• Zhang L, Rajan V, Lin E, Hu Z, Han HQ, Zhou X, et al. Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease. FASEB J 2011;25:1653–1663.
   PubMedGoogle Scholar
• Sartori R, Milan G, Patron M, Mammucari C, Blaauw B, Abraham R, et al. Smad2 and 3 transcription factors control muscle mass in adulthood. Am J Physiol Cell Physiol 2009;296:C1248–C1257.
   PubMed Web of Science ®Google Scholar
• Zhou X, Wang JL, Lu J, Song Y, Kwak KS, Jiao Q, et al. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 2010;142:531–543.
   PubMed Web of Science ®Google Scholar
• Zheng B, Ohkawa S, Li H, Roberts-Wilson TK, Price SR. FOXO3a mediates signaling crosstalk that coordinates ubiquitin and atrogin-1/MAFbx expression during glucocorticoid-induced skeletal muscle atrophy. FASEB J 2010;24:2660–2669.
   PubMedGoogle Scholar
• Hu Z, Wang H, Lee IH, Du J, Mitch WE. Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice. J Clin Invest 2009;119:3059–3069.
   PubMed Web of Science ®Google Scholar
• Zhang L, Du J, Hu Z, Han G, Delafontaine P, Garcia G, et al. IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting. J Am Soc Nephrol 2009;20:604–612.
   PubMedGoogle Scholar
• Murton AJ, Constantin D, Greenhaff PL. The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy. Biochim Biophys Acta 2008;1782:730–743.
   PubMedGoogle Scholar
• Workeneh BT, Rondon-Berrios H, Zhang L, Hu Z, Ayehu G, Ferrando A, et al. Development of a diagnostic method for detecting increased muscle protein degradation in patients with catabolic conditions. J Am Soc Nephrol 2006;17:3233–3239.
   PubMed Web of Science ®Google Scholar
• Lu Y, Adegoke OAJ, Nepveu A, Nakayama KI, Bedard N, Wing SS. USP19 deubiquitinating enzyme supports cell proliferation by stabilizing KPC1, a ubiquitin protein ligase for p27Kip1. Mol Cell Biol 2009;29:547–558.
   PubMedGoogle Scholar
• Medina R, Wing S, Goldberg AL. Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. Biochem J 1995;307:631–637.
   Google Scholar
• Llovera M, Garcia-Martinez C, Agell N, Marzabal M, Lopez-Soriano FJ, Argiles JM. Ubiquitin gene expression is increased in skeletal muscle of tumour-bearing rats. FEBS Letters 1994;338:311–318.
   PubMed Web of Science ®Google Scholar
• Wing SS, Banville D. 14-kDa ubiquitin-conjugating enzyme: structure of the rat gene and regulation upon fasting and by insulin. Amer J Physiol 1994;267:E39–E48.
   Google Scholar
• Li YP, Lecker SH, Chen Y, Waddell ID, Goldberg AL, Reid MB. TNF-alpha increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k. FASEB J 2003;17:1048–1057.
   PubMed Web of Science ®Google Scholar
• Chrysis D, Underwood LE. Regulation of components of the ubiquitin system by insulin-like growth factor I and growth hormone in skeletal muscle of rats made catabolic with dexamethasone. Endocrinology 1999;140:5635–5641.
   Google Scholar
• Fischer D, Sun X, Gang G, Pritts T, Hasselgren PO. The gene expression of ubiquitin ligase E3alpha is upregulated in skeletal muscle during sepsis in rats - potential role of glucocorticoids. Biochem Biophys Res Commun 2000;267:504–508.
   Google Scholar
• Lecker SH, Solomon V, Price SR, Kwon YT, Mitch WE, Goldberg AL. Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats. J Clin Invest 1999;104:1411–1420.
   PubMed Web of Science ®Google Scholar
• Kwon YT, Xia Z, Davydov IV, Lecker SH, Varshavsky A. Construction and analysis of mouse strains lacking the ubiquitin ligase UBR1 (E3alpha) of the N-end rule pathway. Mol Cell Biol 2001;21:8007–8021.
   PubMed Web of Science ®Google Scholar
• Ilian MA, Forsberg NE. Gene expression of calpains and their specific endogenous inhibitor, calpastatin, in skeletal muscle of fed and fasted rabbits. Biochem J 1992;287:163–171.
   PubMedGoogle Scholar
• Price SR, England BK, Bailey JL, Van Vreede K, Mitch WE. Acidosis and glucocorticoids concomitantly increase ubiquitin and proteasome subunit mRNAs in rat muscle. Am J Physiol Cell Physiol 1994;267:C955–C960.
   Google Scholar
• Tiao G, Hobler S, Wang JJ, Meyer TA, Luchette FA, Fischer JE, et al. Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. J Clin Invest 1997;99:163–168.
   Google Scholar
• Taillandier D, Aurousseau E, Meynial-Denis D, Bechet D, Ferrara M, Cottin P, et al. Coordinate activation of lysosomal, Ca 2+-activated and ATP-ubiquitin-dependent proteinases in the unweighted rat soleus muscle. Biochem J 1996;316:65–72.
   Google Scholar
• Williams A, Sun X, Fischer JE, Hasselgren PO. The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer. Surgery 1999;126:744–749.
   PubMedGoogle Scholar
• Fang CH, Li BG, Fischer DR, Wang JJ, Runnels HA, Monaco JJ, et al. Burn injury upregulates the activity and gene expression of the 20 S proteasome in rat skeletal muscle. Clin Sci (Lond) 2000;99:181–187.
   Google Scholar
• Combaret L, Ralliere C, Taillandier D, Tanaka K, Attaix D. Manipulation of the ubiquitin-proteasome pathway in cachexia: pentoxifylline suppresses the activation of 20S and 26S proteasomes in muscles from tumor-bearing rats. Mol Biol Rep 1999;26:95–101.
   PubMed Web of Science ®Google Scholar
• Lorite MJ, Smith HJ, Arnold JA, Morris A, Thompson MG, Tisdale MJ. Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF). Br J Cancer 2001;85:297–302.
   PubMed Web of Science ®Google Scholar
• Kamei Y, Miura S, Suzuki M, Kai Y, Mizukami J, Taniguchi T, et al. Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J Biol Chem 2004;279:41114–41123.
   PubMed Web of Science ®Google Scholar
• Raffaello A, Milan G, Masiero E, Carnio S, Lee D, Lanfranchi G, et al. JunB transcription factor maintains skeletal muscle mass and promotes hypertrophy. J Cell Biol 2010;191:101–113.
   Google Scholar